CLOs on the Move

Washington Hospital Healthcare System

www.whhs.com

 
Washington Hospital Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Washington Hospital Healthcare System is based in Fremont, CA. You can find more information on Washington Hospital Healthcare System at www.whhs.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.whhs.com
  • 2000 Mowry Ave
    Fremont, CA USA 94538
  • Phone: 510.797.1111

Executives

Name Title Contact Details

Similar Companies

Ladd Research Group

Ladd Research Group is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mattson Jack Group

Mattson Jack Group is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Saint Louis, MO. To find more information about Mattson Jack Group, please visit www.mattsonjack.com

Inspyr Therapeutics

Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.

Biography Identity

Biography Identity is a Bellingham, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.